• Home
  • About ADHD
    • ADHD Overview
    • Neurobiology of ADHD
    • Adult ADHD
    • Childhood ADHD
    • ADHD Treatment
  • Services
    • In-Office ADHD Testing
    • In-Home ADHD Testing
    • The Evaluation Process
  • Patient Info
    • ADHD Evaluation Fees
    • Financial Policies
    • Office Policies
    • Insurances Accepted
    • Financing - Care Credit
    • Forms
  • Contact
  • More
    • Home
    • About ADHD
      • ADHD Overview
      • Neurobiology of ADHD
      • Adult ADHD
      • Childhood ADHD
      • ADHD Treatment
    • Services
      • In-Office ADHD Testing
      • In-Home ADHD Testing
      • The Evaluation Process
    • Patient Info
      • ADHD Evaluation Fees
      • Financial Policies
      • Office Policies
      • Insurances Accepted
      • Financing - Care Credit
      • Forms
    • Contact

  • Home
  • About ADHD
    • ADHD Overview
    • Neurobiology of ADHD
    • Adult ADHD
    • Childhood ADHD
    • ADHD Treatment
  • Services
    • In-Office ADHD Testing
    • In-Home ADHD Testing
    • The Evaluation Process
  • Patient Info
    • ADHD Evaluation Fees
    • Financial Policies
    • Office Policies
    • Insurances Accepted
    • Financing - Care Credit
    • Forms
  • Contact

adhd testing massachusetts adhd testing for adults adult adh

What is ADHD?

ADHD, or Attention-Deficit/Hyperactivity Disorder, is a neurodevelopmental disorder commonly diagnosed in children but continue into adulthood in about two-thirds of cases.   According to the DSM-5, several symptoms are required to be present before the age of 12. Many parents report excessive motor activity during the toddler years, but ADHD symptoms can be hard to distinguish from the impulsivity, inattentiveness and active behavior that is typical for kids under the age of four. In making the diagnosis adhd testing massachusetts, children should have six or more symptoms of the disorder present; adhd testing for adults and adolescents 17 and older should have at least five of the symptoms present.  


It is characterized by persistent patterns of inattention, hyperactivity, and impulsivity that interfere with daily functioning across multiple settings such as school, work, and home. ADHD can lead to difficulties in school, relationships, and work if not managed properly, but it is highly treatable through adult adhd treatment which includes behavior therapy, medication, or a combination of both. 


The DSM-5 lists three subtypes of ADHD:

  1. Predominantly Inattentive Presentation: Mostly inattention without significant hyperactivity-impulsivity. 
  2. Predominantly Hyperactive-Impulsive Presentation: Primarily hyperactivity and impulsivity without notable inattention.
  3. Combined Presentation: A mix of both inattentive and hyperactive-impulsive symptoms. 


Common comorbidities

ADHD often coexists with other mental health disorders. Common comorbidities include anxiety disorders like generalized or social anxiety, and depressive disorders. Oppositional Defiant Disorder (ODD) and Conduct Disorder are frequently seen in children and adolescents with ADHD, characterized by defiant or aggressive behaviors. Additionally, individuals with ADHD may face learning disabilities that impact academic performance, and there is an increased risk of substance use disorders in teens and adults. Less commonly, ADHD may overlap with bipolar disorder and autism spectrum disorder (ASD), affecting mood regulation and social communication, respectively.


Causes of ADHD

ADHD is believed to result from a combination of genetic, environmental, and neurological factors. Differences in brain structure, particularly in areas related to attention and impulse control, have been noted in individuals with ADHD. 


ADHD statistics for 2024 highlight its growing prevalence and impact on both children and adults:

  1. Prevalence in Children: Approximately 11.3% of children aged 5-17 have been diagnosed with ADHD in the U.S., with boys (17.9%) being more frequently diagnosed than girls (10.4%). Children from lower-income families and those with public health insurance are also more likely to have ADHD. 
  2. Comorbidities: Around 60% of children with ADHD have another emotional or behavioral condition, such as anxiety, depression, or conduct disorders. 
  3. Oppositional Defiant Disorder (ODD) occurs in about 40% of children with ADHD, while 27% of children with ADHD may also develop Conduct Disorder (CD). 
  4. 56% of adults with ADHD experience anxiety disorders. 
  5. Prevalence in Adults: Roughly 4.4% of adults in the U.S. have ADHD, and about 41.3% of these cases are considered severe. Most adults with ADHD were diagnosed in childhood, though many discover it later in life.

Serious Consequences of Untreated ADHD: Risks and the Importance of Early Intervention

According to research by ADHD expert Dr. Russell Barkley, untreated ADHD can have significant long-term consequences, including a reduction in life expectancy. Barkley's studies suggest that ADHD can reduce life expectancy by up to 13 years. This is due to a combination of factors associated with ADHD, such as impulsive behavior, poor self-care, and increased risk of high-risk activities like smoking, accidents and injuries, and substance abuse. ADHD also impacts health behaviors, including poor diet and lack of exercise, further compounding these risks.


In addition to reduced life expectancy, individuals with untreated ADHD are more prone to developing co-occurring mental health issues, such as anxiety and depression, and face challenges in academic, occupational, and social settings. The combination of these risks makes untreated ADHD a significant public health concern. adult adhd treatment adhd testing for children in massachusetts adhd testing for adults to identify ADHD early can mitigate many of these risks, with treatment potentially adding 9 to 13 years to life expectancy. Early diagnosis through adhd testing massachusetts and intervention can significantly reduce these risks, making it critical to identify and treat ADHD early to improve long-term outcomes in children and adults.


 References:

  • Barkley, R. A., & Fischer, M. (2019). "Hyperactive Child Syndrome and Estimated Life Expectancy at Young Adult Follow-Up: The Role of ADHD Persistence and Other Potential Predictors." Journal of Attention Disorders. This study found that untreated ADHD can reduce life expectancy by 9 to 13 years​
    Russell Barkley ​CHADD.
  • CHADD (2019). "New Research Suggests Untreated ADHD Reduces Life Expectancy." This article discusses Barkley's findings on the impact of untreated ADHD, comparing it to major health risks like smoking and poor diet​ CHADD.

  • ADHD Evaluation Fees
  • Financing - Care Credit
  • Privacy Policy

Aspire ADHD

275 Turnpike St. Ste 206 | Canton, MA 02021

(781) 996-0046

Copyright © 2024 www.aspireadhd.com -  All Rights Reserved. 

In-Office Telehealth ADHD Testing Massachusetts

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept